Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
End price
08.09.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Atara Biotherapeutics Inc. is performing very badly with a performance of -74.00%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atara Biotherapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.224% | 1.805% | 3.203% |
| iShares Nasdaq 100 | 6.047% | 15.716% | 39.608% |
| iShares Nikkei 225® | 5.724% | 12.343% | 50.337% |
| iShares S&P 500 | 2.172% | 7.723% | 26.167% |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year